By Daniel Wiessner A group of Democratic U.S. state attorneys general on Wednesday pushed back against claims by

Reddit's most popular third-party app, Apollo, will shut down due to new API fees Reddit's

Major improvements are coming to Modern Warfare 3, including slide cancelling, reload cancelling, the Ninja Perk, red dots, and more.

TL;DR: As of September 5, get The All-in-One Microsoft Office Pro 2021 for Windows: Lifetime

Google is rolling out new artificial intelligence tools to help marketers create advertisements, seeking to expand its use

EU ministers agreed stronger rules Tuesday to crack down on the use of cryptocurrencies in tax fraud, as Brussels bolsters its efforts...

The world's major tech titans must crack down on illegal content and keep European users safe online from Friday, when far-reaching EU rules force digital...

Scientists have developed an artificial intelligence (AI) tool that can classify four subtypes of Parkinson’s disease with up to 95% accuracy. Researchers from the Francis Crick Institute and the UCL Queen Square Institute of Neurology in London “trained” a computer program to recognise the subtypes of the condition using images of stem cells from patients. The team said their work, published in the journal Nature Machine Intelligence, could pave the way for personalised medicine and targeted drug discovery. Sonia Gandhi, assistant research director and group leader of the Neurodegeneration Biology Laboratory at the Crick, said: “We understand many of the processes that are causing Parkinson’s in people’s brains. The hope is that one day this could lead to fundamental changes in how we deliver personalised medicine Sonia Gandhi, Francis Crick Institute “But, while they are alive, we have no way of knowing which mechanism is happening, and therefore can’t give precise treatments. “We don’t currently have treatments which make a huge difference in the progression of Parkinson’s disease. “Using a model of the patient’s own neurons, and combining this with large numbers of images, we generated an algorithm to classify certain subtypes – a powerful approach that could open the door to identifying disease subtypes in life. “Taking this one step further, our platform would allow us to first test drugs in stem cell models, and predict whether a patient’s brain cells would be likely to respond to a drug, before enrolling into clinical trials. “The hope is that one day this could lead to fundamental changes in how we deliver personalised medicine.” Parkinson’s is a condition in which parts of the brain become progressively damaged over many years. Symptoms include involuntary shaking of particular parts of the body, slow movement, and stiff and inflexible muscles. But there is also a wide range of other physical and psychological symptoms such as depression and anxiety, problems sleeping, and memory problems. These vary from person to person due to differences in the underlying mechanisms causing the disease. The researchers said that until now, there was no way to accurately differentiate Parkinson’s subtypes. It means people are given nonspecific diagnoses and do not always have access to targeted treatments, support or care, the team added. For the study, the researchers generated stem cells, which have the ability to develop into specialised cell types in the body, from patients’ own cells. The team then used those cells to chemically create four different subtypes of Parkinson’s: two involving pathways leading to toxic build-up of a protein called alpha-synuclein and two involving pathways associated with dysfunctional mitochondria, the cell’s battery packs. Working with the British technology company Faculty AI, the team developed machine-learning algorithms which were able to accurately predict the Parkinson’s subtype when presented with images it had not seen before. James Evans, a PhD student at the Crick and UCL, and first co-author of the study, said: “Now that we use more advanced image techniques, we generate vast quantities of data, much of which is discarded when we manually select a few features of interest. “Using AI in this study enabled us to evaluate a larger number of cell features, and assess the importance of these features in discerning (the) disease subtype. “Using deep learning, we were able to extract much more information from our images than with conventional image analysis. “We now hope to expand this approach to understand how these cellular mechanisms contribute to other subtypes of Parkinson’s.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Oxford scientists find no evidence to suggest Facebook not good for wellbeing Many adults would struggle to understand video-sharing platforms’ rules – Ofcom Ozzy Osbourne PlayStation tweet which failed to reveal link to Sony banned

Indonesian livestreamer Christine Febriyanti stood in a room crammed with clothes in Jakarta, hawking colourful garments to hundreds of viewers on a TikTok livestream...

SINGAPORE--(BUSINESS WIRE)--Jun 13, 2023--

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aug 16, 2023--

Xinjiang Goldwind Science & Technology Co., the largest wind-turbine maker, said profit plunged as a price war continues